François Cherbonneau, Ph.D.
CEO, co-founder and inventor of the technology
Holds a PhD in Biotechnologies/Genetics from a co-thesis program between Université de Paris and Massachusetts General Hospital/Harvard Medical School, and an engineering degree in Biotechnologies from Ecole de Biologie Industrielle. His management training is from the HEC Paris (Challenge +).
More than 5 years of experience in molecular designs for sequencing and genome editing technologies.